✦ LIBER ✦

The efficacy of pemetrexed as a third- or fourth-line therapy and the significance of thymidylate synthase expression in patients with advanced non-small cell lung cancer

✍ Scribed by Chang, Myung Hee; Ahn, Jin Seok; Lee, Jeeyun; Kim, Kyoung Ha; Park, Yeon Hee; Han, Joungho; Ahn, Myung-Ju; Park, Keunchil

Book ID: 119320317
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 466 KB
Volume: 69
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2009.12.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Thymidylate synthase and dihydrofolate r

Thymidylate synthase and dihydrofolate reductase expression in non-small cell lung carcinoma: The association with treatment efficacy of pemetrexed

✍ Chen, Chung-Yu; Chang, Yih-Leong; Shih, Jin-Yuan; Lin, Jou-Wei; Chen, Kuan-Yu; Y 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 942 KB

A Randomized Phase II Study of Pemetrexe

A Randomized Phase II Study of Pemetrexed in Combination With Cisplatin or Carboplatin as First-Line Therapy for Patients With Locally Advanced or Metastatic Non–Small-Cell Lung Cancer

✍ Schuette, Wolfgang H.W.; Gröschel, Andreas; Sebastian, Martin; Andreas, Stefan; 📂 Article 📅 2013 🏛 CIG Media Group, LP. 🌐 English ⚖ 534 KB

Targeted agents in the third-/fourth-lin

Targeted agents in the third-/fourth-line treatment of patients with advanced (stage III/IV) non-small cell lung cancer (NSCLC)

✍ Langer, Corey J.; Mok, Tony; Postmus, Pieter E. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 235 KB

Randomized Phase III Trial of Erlotinib

Randomized Phase III Trial of Erlotinib Versus Docetaxel As Second- or Third-Line Therapy in Patients With Advanced Non-Small-Cell Lung Cancer: Docetaxel and Erlotinib Lung Cancer Trial (DELTA)

✍ Kawaguchi, T.; Ando, M.; Asami, K.; Okano, Y.; Fukuda, M.; Nakagawa, H.; Ibata, 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 183 KB

Thymidylate synthase and dihydropyrimidi

Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA levels in tumor tissues and the efficacy of 5-fluorouracil in patients with non-small-cell lung cancer

✍ Shintani, Yasushi; Ohta, Mitsunori; Hirabayashi, Hirohisa; Tanaka, Hisaichi; Iuc 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 295 KB

Prevalence and effectiveness of first-,

Prevalence and effectiveness of first-, second-, and third-line systemic therapy in a cohort of unselected patients with advanced non-small cell lung cancer

✍ Zietemann, V.; Duell, T. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 243 KB